Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization

References

• KonesRRecent advances in the management of chronic stable angina I. Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparitiesVasc Health Risk Manag2010663565620730020
   PubMedGoogle Scholar
• van DamRMWillettWCUnmet potential for cardiovascular disease prevention in the United StatesCirculation20091201171117319752318
   PubMed Web of Science ®Google Scholar
• GrundySMPrevention of atherosclerotic cardiovascular disease: why are the benefits of lifestyle therapies neglectedDialogues Cardiovasc Med2005117386
   Google Scholar
• FoxKGarciaMAArdissinoDfor Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG)Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of CardiologyEur Heart J2006271341138116735367
   PubMed Web of Science ®Google Scholar
• GibbonsRJAbramsJChatterjeeKACC/AHA 2002 guideline update for the management of patients with chronic stable angina –summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina)J Am Coll Cardiol20034115916812570960
   PubMedGoogle Scholar
• O’RourkeSTNitro vasodilators: pharmacology and use in the treatment of myocardial ischemiaAm J Pharm Educ200266177180
   Web of Science ®Google Scholar
• LacosteLLTherouxPLidonRMAntithrombotic properties of transdermal nitroglycerin in stable angina pectorisAm J Cardiol19947315105810628198030
   PubMed Web of Science ®Google Scholar
• GoriTParkerJDLong-term therapy with organic nitrates. The pros and cons of nitric oxide replacement therapyJ Am Coll Cardiol20044463263415358032
   PubMed Web of Science ®Google Scholar
• SchiffrinELOxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulationHypertension200851313218071058
   PubMed Web of Science ®Google Scholar
• BergesANassauwLVTimmermansJPVrintsCRole of nitric oxide during coronary endothelial dysfunction after myocardial infarctionEuro J Pharmacol2005 2351616070
   PubMed Web of Science ®Google Scholar
• BottcherMMadsenMMRandsbaekFEffect of oral nitroglycerin and cold stress on myocardial perfusion in areas subtended by stenosed and nonstenosed coronary arteriesAm J Cardiol2002891019102411988188
   PubMed Web of Science ®Google Scholar
• TadamuraEMamedeMKuboSThe effect of oral nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECTJ Nucl Med20034474575112732676
   PubMed Web of Science ®Google Scholar
• DumontLLeLorierJStanleyPChartrandCEffect of nitroglycerin on regional myocardial blood flow following an experimental coronary spasmAngiology19843595535596435485
   PubMed Web of Science ®Google Scholar
• AbramsJNitroglycerin and long-acting nitrates in clinical practiceAm J Med19837485946407316
   PubMed Web of Science ®Google Scholar
• ThadaniUNitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failureCardiovasc Drugs Ther1997107357429110117
   PubMed Web of Science ®Google Scholar
• ParkerJOFarrellBLaheyKAEffect of intervals between doses on the development of tolerance to isosorbide dinitrateN Engl J Med1987316144014443574424
   PubMed Web of Science ®Google Scholar
• de MotsHGlasserSPIntermittent transdermal nitroglycerin therapy in the treatment of chronic stable anginaJ Am Coll Cardiol1989137867952494240
   PubMedGoogle Scholar
• DaiberAMülschAHinkUThe oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazineAm J Cardiol2005967B25i36i15979427
   PubMed Web of Science ®Google Scholar
• MünzelTSayeghHFreemanBATarpeyMMHarrisonDGEvidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-toleranceJ Clin Invest19959511871947814613
   PubMed Web of Science ®Google Scholar
• JakschikBNeedlemanPSulfhydryl reactivity of organic nitrates: biochemical basis for inhibition of glyceraldehyde-P dehydrogenase and monoamine oxidaseBiochem Biophys Res Commun1973535395444197820
   PubMed Web of Science ®Google Scholar
• DaiberAOelzeMWenzelPNitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stressPharmacol Rep2009611334819307691
   PubMed Web of Science ®Google Scholar
• ChenZZhangJStamlerJSIdentification of the enzymatic mechanism of nitroglycerin bioactivationProc Natl Acad Sci U S A2002998306831112048254
   PubMed Web of Science ®Google Scholar
• KnotHJNitrate tolerance in hypertension: new insight into a century-old problemCirc Res20039379980114592995
   PubMed Web of Science ®Google Scholar
• GerzanichVIvanovAIvanovaSAlternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: novel mechanism for nitrate tolerance in vascular smooth muscleCirc Res20039380581214512447
   PubMed Web of Science ®Google Scholar
• CheitlinMDHutterAMJrBrindisRGACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular diseaseJ Am Coll Cardiol1999332732829935041
   PubMed Web of Science ®Google Scholar
• PepineCJCohnPFDeedwaniaPCEffects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)Circulation1994907627688044945
   PubMed Web of Science ®Google Scholar
• FreemantleNClelandJYoungPβ-blockade after myocardial infarction: systematic review and meta regression analysisBr Med J19993181730173710381708
   PubMed Web of Science ®Google Scholar
• MillerRROlsonHGAmsterdamEAPropranolol withdrawal rebound phenomenon: exacerbation of coronary events after abrupt cessation of antianginal therapyN Engl J Med19752934164181097925
   PubMed Web of Science ®Google Scholar
• PsatyBMKoepsellTDWagnerEHThe relative risk of incident coronary heart disease associated with recently stopping the use of β-blockersJAMA1990263165316571968518
   PubMed Web of Science ®Google Scholar
• HeidenreichPAMcDonaldKMHastieTMeta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable anginaJAMA19992811927193610349897
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuEMLibbyPfor the CAMELOT InvestigatorsEffect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trialJAMA20042922217222515536108
   PubMed Web of Science ®Google Scholar
• RiceKRGervinoEJarischWRStonePHEffects of nifedipine on myocardial perfusion during exercise in chronic stable anginaAm J Cardiol199065109711012184649
   PubMed Web of Science ®Google Scholar
• TappRJSharpAStantonAVfor the ASCOT InvestigatorsDifferential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) SubstudyJ Am Coll Cardiol2010551875188120413040
   PubMed Web of Science ®Google Scholar
• PepineCJHandbergEMCooper-DeHoffRMfor the INVEST InvestigatorsA calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trialJAMA20032902805281614657064
   PubMed Web of Science ®Google Scholar
• Poole-WilsonPALubsenJKirwanBAEffect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trialLancet200436484985715351192
   PubMed Web of Science ®Google Scholar
• SierraCCocaAThe ACTION study: nifedipine in patients with symptomatic stable angina and hypertensionExpert Rev Cardiovasc Ther2008681055106218793108
   PubMedGoogle Scholar
• PackerMO’ConnorCMGhaliJKEffect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study GroupN Engl J Med1996335110711148813041
   PubMed Web of Science ®Google Scholar
• GoldsteinREBoccuzziSJCruessDNattelSDiltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research GroupCirculation19918352601984898
   PubMed Web of Science ®Google Scholar
• KonesRAfter cardiac surgery, how does nutrition fit in with risk factors?J Parent Enteral Nutr2010342163167
   PubMed Web of Science ®Google Scholar
• LeonMBRosingDRBonowROEpsteinSECombination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectorisAm J Cardiol19855569B80B
   PubMed Web of Science ®Google Scholar
• WaysbortJMeshulamNBrunnerDIsosorbide-5-mononitrate and atenolol in the treatment of stable exertional anginaCardiology199179Suppl 219261760824
   PubMed Web of Science ®Google Scholar
• PepineCJAbramsJMarksRGCharacteristics of a contemporary population with angina pectoris. TIDES investigatorsAm J Cardiol1994742262318037126
   PubMed Web of Science ®Google Scholar
• MannheimerCCamiciPChesterMRThe problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory AnginaEur Heart J20022335537011846493
   PubMed Web of Science ®Google Scholar
• JahangirATerzicAShenWKPotassium channel openers: therapeutic potential in cardiology and medicineExpert Opin Pharmacother200121995201011825331
   PubMedGoogle Scholar
• ZingmanLVAlekseevAEHodgson-ZingmanDMTerzicAATP-sensitive potassium channels: metabolic sensing and cardioprotectionJ Appl Physiol200710351888189317641217
   PubMed Web of Science ®Google Scholar
• JahangirATerzicAK(ATP) channel therapeutics at the bedsideJ Mol Cell Cardiol2005399911215953614
   PubMed Web of Science ®Google Scholar
• JohnSAWeissJNXieLHRibaletBMolecular mechanism for ATP-dependent closure for the K+ channel Kir6.2J Physiol (Lond)2003552233412860923
   PubMedGoogle Scholar
• IONA Study GroupEffect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trialLancet20023591269127511965271
   PubMed Web of Science ®Google Scholar
• MarkhamAPloskerGLGoaKLNicorandil: an updated review of its use in ischemic heart disease with emphasis on its cardioprotective effectsDrugs20006095597411085202
   PubMed Web of Science ®Google Scholar
• CiampricottiRSchotborghCEde KamPJvan HerwaardenRHA comparison of nicorandil with isosorbide mononitrate in elderly patients with stable coronary heart disease: the SNAPE StudyAmer Heart J2000139593994310827372
   PubMed Web of Science ®Google Scholar
• SimpsonDWellingtonKNicorandil: a review of its use in the management of stable angina pectoris, including high-risk patientsDrugs2004641941195515329045
   PubMed Web of Science ®Google Scholar
• SavelievaICamAJIf inhibition with ivabradine: electrophysiological effects and safetyDrug Saf2008319510718217787
   PubMed Web of Science ®Google Scholar
• BorerJSFoxKJaillonPLereboursGfor Ivabradine Investigators GroupAntianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trialCirculation200310781782312591750
   PubMed Web of Science ®Google Scholar
• Lopez-BescosLFilipovaSMartosRLong-term safety and efficacy of ivabradine in patients with chronic stable anginaCardiology200710838739617890862
   PubMed Web of Science ®Google Scholar
• TardifJCFordITenderaMBourassaMGFoxKfor INITIATIVE InvestigatorsEfficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable anginaEur Heart J2005262529253616214830
   PubMed Web of Science ®Google Scholar
• RuzylloWTenderaMFordIFoxKMAntianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trialDrugs20076739340517335297
   PubMed Web of Science ®Google Scholar
• FoxKFordIStegPGTenderaMFerrariRfor BEAUTIFUL InvestigatorsIvabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trialLancet200837280781618757088
   PubMed Web of Science ®Google Scholar
• TardifJCPonikowskiPKahanTfor the ASSOCIATE Study InvestigatorsEfficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4 month, randomized, placebo-controlled trialEur Heart J20093054054819136486
   PubMed Web of Science ®Google Scholar
• MarzilliMDoes timetazidine prevent myocardial injury after percutaneous coronary interventionNat Clin Pract Cardiovasc Med20085161717940516
   PubMedGoogle Scholar
• StanleyWCMarzilliMMetabolic therapy in the treatment of ischemia heart disease: the pharmacology of trimetazidineFundam Clin Pharmacol20031713314512667223
   PubMed Web of Science ®Google Scholar
• KantorPFLucienAKozakRLopaschukGDThe antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolaseCirc Res20008658058810720420
   PubMed Web of Science ®Google Scholar
• ChazovEILepakchinVKZharovaEATrimetazidine in angina combination therapy – the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter studyAm J Ther200512354215662290
   PubMedGoogle Scholar
• KolbelFBadaVTrimetazidine in geriatric patients with stable angina pectoris: the TIGER studyInt J Clin Pract20035786787014712887
   PubMed Web of Science ®Google Scholar
• CiapponiAPizarroRHarrisonJTrimetazidine for stable anginaCochrane Database of Systematic Reviews20054CD003614
   PubMedGoogle Scholar
• TuunanenHEngblomENaumATrimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathyCirculation20081181250125818765391
   PubMed Web of Science ®Google Scholar
• FragassoGPalloshiAPuccettiPA randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failureJ Am Coll Cardiol20064899299816949492
   PubMed Web of Science ®Google Scholar
• CeraMSalernoAFragassoGBeneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failureJ Cardiovasc Pharmacol Ther2010151243020100903
   PubMed Web of Science ®Google Scholar
• VicariRMChaitmanBKeefeDfor Fasudil Study GroupEfficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trialJ Am Coll Cardiol2005461803181116286163
   PubMed Web of Science ®Google Scholar
• BarthASTomaselliGFCardiac metabolism and arrhythmiasCirc Arrhythm Electrophysiol2009232733519808483
   PubMed Web of Science ®Google Scholar
• BelardinelliLAntzelevitchCFraserHInhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium dependent calcium overload and its detrimental effects on cardiomyocyte functionEur Heart J200461317
   Web of Science ®Google Scholar
• UndrovinasAIBelardinelliLUndrovinasNARanolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium currentJ Cardiovasc Electrophysiol200617Suppl 1S169S17716686675
   PubMedGoogle Scholar
• MaltsevVASabbahHNHigginsRSDSilvermanNLeschMUndrovinasAINovel, ultraslow inactivating sodium current in human ventricular cardiomyocytesCirculation199898254525529843461
   PubMed Web of Science ®Google Scholar
• PikeMMKitakazeMMarbanENa-NMR measurement of intracellular sodium in intact perfused ferret hearts during ischemia and reperfusionAm J Physiol1990259H1767H17732260701
   PubMedGoogle Scholar
• AntzelevitchCBelardinelliLZygmuntACElectrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic propertiesCirculation200411090491015302796
   PubMed Web of Science ®Google Scholar
• BersDMBarryWHDespaSIntracellular Na+ regulation in cardiac myocytesCardiovasc Res20035789791212650868
   PubMed Web of Science ®Google Scholar
• MurphyECrossHSteenbergenCSodium regulation during ischemia versus reperfusion and its role in injuryCirc Res1999841469147010381900
   PubMed Web of Science ®Google Scholar
• KusuokaHMarbanECellular mechanisms of myocardial stunningAnnu Rev Physiol1992542432561562175
   PubMed Web of Science ®Google Scholar
• KusuokaHHurtadoMCCMarbanERole of sodium/calcium exchange in the mechanism of stunning: protective effect of reperfusion with high sodium solutionJ Am Coll Cardiol1993212402488417067
   PubMed Web of Science ®Google Scholar
• ImahashiKKusuokaHHashimotoKYoshiokaJYamaguchiHNishimuraTIntracellular sodium accumulation during ischemia as the substrate for reperfusion injuryCirc Res1999841401140610381892
   PubMed Web of Science ®Google Scholar
• ImahashiKMraicheFSteenbergenCMurphyEFliegelLOver-expression of the Na+/H+ exchanger and ischemia-reperfusion injury in the myocardiumAm J Physiol Heart Circ Physiol20072925H2237H224717209001
   PubMed Web of Science ®Google Scholar
• TaegtmeyerHModulation of responses to myocardial ischemia: metabolic features of myocardial stunning, hibernation, and ischemic preconditioningDilsizianVMyocardial Viability: A Clinical and Scientific TreatiseArmonk, New YorkFutura Publishing20002536
   Google Scholar
• BakerCRimoldiOCamiciPRepetitive myocardial stunning in pigs is associated with the increased expression of inducible and constitutive nitric oxide synthasesCardiovasc Res199943368569710690340
   PubMed Web of Science ®Google Scholar
• TaniMNeelyJRRole of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchangeCirc Res198965104510562551525
   PubMed Web of Science ®Google Scholar
• BelardinelliLShryockJCFraserHInhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazineHeart200692Suppl 4iv6iv1416775092
   PubMedGoogle Scholar
• ChaitmanBRRanolazine for the treatment of chronic angina and potential use in other cardiovascular conditionsCirculation20061132462247216717165
   PubMed Web of Science ®Google Scholar
• WasserstromJASharmaRO’TooleMJRanozaline antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heartJ Pharmacol Exp Ther2009331238239119675298
   PubMed Web of Science ®Google Scholar
• SteenbergenCMurphyELevyLLondonREElevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heartCirc Res1987607007073109761
   PubMed Web of Science ®Google Scholar
• HayashidaWvan EyllCRousseauMFPouleurHEffects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart diseaseCardiovasc Drugs Ther199487417477873471
   PubMed Web of Science ®Google Scholar
• JerlingMHuanBHLeungKChuNAbdallahHHusseinZStudies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjectsJ Clin Pharmacol20054542243315778423
   PubMed Web of Science ®Google Scholar
• MingEEDavidsonMHGandiSKConcomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databasesJ Clin Lipidol20082453463
   PubMed Web of Science ®Google Scholar
• DrewBJAckermanMJFunkMfor the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular Nursing, and the American College of Cardiology FoundationPrevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology FoundationJ Am Coll Cardiol201055993494720185054
   PubMed Web of Science ®Google Scholar
• SauerAJMossAJMcNittSLong QT syndrome in adultsJ Am Coll Cardiol20074932933717239714
   PubMed Web of Science ®Google Scholar
• BelardinelliLAntzelevitchCVosMAAssessing predictors of drug-induced torsade de pointesTrends Pharmacol Sci20032461962514654302
   PubMed Web of Science ®Google Scholar
• PepineCJWolffAAA controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional anti-anginal agentsAm J Cardiol199984465010404850
   PubMed Web of Science ®Google Scholar
• RousseauMFPouleurHCoccoGWolffAAComparative efficacy of ranolazine versus atenolol for chronic angina pectorisAm J Cardiol20059531132615670536
   PubMed Web of Science ®Google Scholar
• ChaitmanBRSkettinoSLParkerJOfor the MARISA InvestigatorsAnti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJ Am Coll Cardiol2004431375138215093870
   PubMed Web of Science ®Google Scholar
• ChaitmanBRPepineCJParkerJOfor the CARISA InvestigatorsEffects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trialJAMA200429130931614734593
   PubMed Web of Science ®Google Scholar
• KorenMJCragerMRSweeneyMLong-term safety of a novel antianginal agent in patients with severe chronic stable angina: the ranolazine open label experience (ROLE)J Am Coll Cardiol2007491027103417349881
   PubMed Web of Science ®Google Scholar
• MarkDBHlatkyMAHarrellFEJrLeeKLCaliffRMPryorDBExercise treadmill score for predicting prognosis in coronary artery diseaseAnn Intern Med19871067938003579066
   PubMed Web of Science ®Google Scholar
• AlexanderKPShawLJDelingERMarkDBPetersonEDValue of exercise treadmill testing in womenJ Am Coll Cardiol199832165716649822093
   PubMed Web of Science ®Google Scholar
• StonePHGratsianskyNABlokhinAHuangIZMengLAntianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine In Chronic Angina) trialJ Am Coll Cardiol20064856657516875985
   PubMed Web of Science ®Google Scholar
• MorrowDASciricaBMKarwatowska-ProkopczukEEffects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes. The MERLIN-TIMI 36 trialJAMA2007297161775178317456819
   PubMed Web of Science ®Google Scholar
• WilsonSRSciricaBMBraunwaldEEfficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN – TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 trialJ Am Coll Cardiol200953171510151619389561
   PubMed Web of Science ®Google Scholar
• MorrowDASciricaBMSabatineMSB-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes 36) trialJ Am Coll Cardiol201055121189119620298924
   PubMed Web of Science ®Google Scholar
• CaliffRMShahSHNewbyLKBiomarker bonanzaJ Am Coll Cardiol2010551197119920298925
   PubMed Web of Science ®Google Scholar
• JaxTWPetersAJKhattabAAHeintzenMPSchoebelFCPercutaneous coronary revascularization in patients with formerly “refractory angina pectoris in end-stage coronary artery disease” – Not “end-stage” after allBMC Cardiovasc Disord2009942 http://www.biomedcentral.com/1471-2261/9/4219715566
   PubMed Web of Science ®Google Scholar
• KonesRMechanical circulatory assistance: present statusN Y State J Med1974745165314594914
   PubMedGoogle Scholar
• MichaelsADAccadMPortsTAGrossmanWLeft ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsationCirculation20021061237124212208799
   PubMed Web of Science ®Google Scholar
• AroraRRLopesSSaricMEnhanced external counterpulsation improves systolic function by echocardiography in patients with coronary artery diseaseHeart Lung20053412212515761457
   PubMed Web of Science ®Google Scholar
• SoranOTreatment options for refractory angina pectoris: enhanced external counterpulsation therapyCurr Treat Options Cardiovasc Med2009111546019141261
   PubMedGoogle Scholar
• BonettiPOBarsnessGWKeelanPCEnhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery diseaseJ Am Coll Cardiol2003411761176812767662
   PubMed Web of Science ®Google Scholar
• CaseyDPContiCRNicholsWWChoiCYKhuddusMABraithRWEffect of enhanced external counterpulsation on inflammatory cytokines and adhesion molecules in patients with angina pectoris and angiographic coronary artery diseaseAm J Cardiol2008101330030218237588
   PubMed Web of Science ®Google Scholar
• AkhtarMWuGFDuZMZhengZSMichaelsADEffect of external counterpulsation on plasma nitric oxide and endothelin-1 levelsAm J Cardiol200698283016784915
   PubMed Web of Science ®Google Scholar
• AroraRRChouTMJainDThe MUlticenter STudy of Enhanced External CounterPulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodesJ Am Coll Cardiol1999331833184010362181
   PubMed Web of Science ®Google Scholar
• MichaelsADLinnemeierGSoranOKelseySFKennardEDTwo-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR])Am J Cardiol20049346146414969624
   PubMed Web of Science ®Google Scholar
• LawsonWEHuiJCZhengZSImproved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effectCardiology1996872712758793157
   PubMed Web of Science ®Google Scholar
• ErdlingABondessonSPettersonTEdvinssonLEnhanced external counterpulsation in treatment of refractory angina pectoris: two year outcome and baseline factors associated with treatment failureBMC Cardiovasc Disord2008813919094202
   PubMedGoogle Scholar
• LawsonWEHuiJCConnPFLong term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up studyClin Cardiol20002325425810763072
   PubMedGoogle Scholar
• BarsheshetAHodHShechterMThe effects of external counter pulsation therapy on circulating endothelial progenitor cells in patients with angina pectorisCardiology2008110316016618057883
   PubMed Web of Science ®Google Scholar
• BravermanDLEnhanced external counterpulsation: an innovative physical therapy for refractory anginaPhys Med Rehabil200913268276
   Google Scholar
• CohnPFEECP – new data on possible mechanisms of actionEur Heart J2001221363136411482912
   PubMed Web of Science ®Google Scholar
• BeainiYMorleyCEECP: a non-invasive therapy for refractory anginaPractitioner20092531715273119326660
   PubMedGoogle Scholar
• KumarAAronowWSVadnerkarAEffect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectorisAm J Ther200916211611819300038
   PubMed Web of Science ®Google Scholar
• CampbellARSatranDZenovichAGEnchanced external counterpulsation improves systolic blood pressure in patients with refractory anginaAm Heart J200815661217122219033023
   PubMed Web of Science ®Google Scholar
• WuMKomoriNQinCFarberJPLinderothBForemanRDRoles of peripheral terminals of transient receptor potential vanilloid-1 containing sensory fibers in spinal cord stimulation-induced peripheral vasodilationBrain Res20071156809217540346
   PubMed Web of Science ®Google Scholar
• MeyersonBALinderothBSpinal cord stimulation: mechanisms of action in neuropathic and ischemic painSimpsonBAElectrical Stimulation and the Relief of Pain15New York, NYElsevier Publishers2003161182
   Google Scholar
• LinderothBForemanRDMechanisms of spinal cord stimulation in painful syndromes: role of animal modelsPain Med20067S14S26
   Web of Science ®Google Scholar
• MannheimerCAugustinssonLECarlssonCAManhemKWilhelmssonCEpidural spinal electrical stimulation in severe angina pectorisBr Heart J19885956613257701
   PubMedGoogle Scholar
• González-DarderJMCanelaPGonzález-MartinezVHigh cervical spinal cord stimulation for unstable angina pectorisStereotact Funct Neurosurg19915620271682982
   PubMed Web of Science ®Google Scholar
• QinCFarberJPLinderothBShahidAForemanRDNeuromodulation of thoracic intraspinal visceroreceptive transmission by electrical stimulation of spinal dorsal column and somatic afferents in ratsJ Pain20089717817974489
   PubMed Web of Science ®Google Scholar
• LinderothBMeyersonBSpinal cord stimulation: mechanisms of actionBurchielKSurgical Management of PainNew York, NYThieme Medical Publishers Inc2002505526
   Google Scholar
• OldroydKGHarveyKGrayCEBeta-endorphin release in patients after spontaneous and provoked acute myocardial ischaemiaBr Heart J1992672302351313275
   PubMedGoogle Scholar
• MannheimerCCarlssonCAEmanuelssonHThe effects of transcutaneous electrical nerve stimulation in patients with severe angina pectorisCirculation19855271116
   Google Scholar
• HaustvastRWMTer HorstGJde JongBMRelative changes in regional cerebral blood flow during spinal cord stimulation in patients with refractory angina pectorisEur J Neurosci19979117811839215701
   PubMed Web of Science ®Google Scholar
• de VriesJde JongsteMJLZijlstraFLong-term effects of electrical neurostimulation in patients with unstable angina. Refractory to conventional therapiesNeuromodulation200710345348
   PubMed Web of Science ®Google Scholar
• SandersonJEIbrahimBWaterhouseDSpinal electrical stimulation for intractable angina – long-term clinical outcome and safetyEur Heart J1994158108148088270
   PubMed Web of Science ®Google Scholar
• AndersenCEnggardTPSchererCSpinal cord stimulation has a proven benefit on pain and quality of life in patients with angina pectoris when less invasive therapies have failedNeuromodulation20069314319
   PubMed Web of Science ®Google Scholar
• EddicksSMaier-HauffKSchenkMThoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised studyHeart20079358559017237126
   PubMed Web of Science ®Google Scholar
• CameronTSafety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20 year literature reviewJ Neurosurg200410025426715029914
   PubMed Web of Science ®Google Scholar
• Di PedeFLanzaGAZuinGImmediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectorisAm J Cardiol20039195195512686334
   PubMed Web of Science ®Google Scholar
• ChauhanAMullinsPAThuraisinghamGEffects of transcutaneous electrical nerve stimulation in coronary blood flowCirculation1994896947028313557
   PubMed Web of Science ®Google Scholar
• EmanuelssonHCMannheimerFWaagsteinCCatecholamine metabolism during pacing-induced angina pectoris and the effect of transcutaneous electrical nerve stimulationAm Heart J1987114136013663500628
   PubMed Web of Science ®Google Scholar
• AnselminoMRaveraLde LucaASpinal cord stimulation and 30-minute heart rate variability in refractory angina patientsPacing Clin Electrophysiol2009321374219140911
   PubMed Web of Science ®Google Scholar
• HautvastRWde JongsteMJStaalMJvan GilstWHLieKISpinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy studyAm Heart J1998136111411209842028
   PubMed Web of Science ®Google Scholar
• MannheimerCEliassonTAugustinssonLEElectrical stimulation versus coronary artery bypass surgery in severe angina pectoris. The ESBY studyCirculation199897115711639537342
   PubMed Web of Science ®Google Scholar
• ErkeOEliassonTNorrsellHLong-term effects of spinal cord stimulation and coronary artery bypass grafting on quality of life and survival in the ESBY studyEur Heart J2002231938194512473256
   PubMed Web of Science ®Google Scholar
• EckertSDongasAGüldnerHImmediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectoris in patients with chronic pacemaker- and ICD-treatmentEur Heart J200627Suppl 6463S
   Google Scholar
• TaylorRSde VriesJBuchserEde JongsteMJSpinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trialsBMC Cardiovasc Disord200991319320999
   PubMed Web of Science ®Google Scholar
• HorvathKATransmyocardial laser revascularizationJ Card Surg20082326627618435649
   PubMed Web of Science ®Google Scholar
• UwatokuTItoKAbeKExtracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigsCoron Artery Dis20071839740417627190
   PubMed Web of Science ®Google Scholar
• FukumotoYItoAUwatokuTExtracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery diseaseCoron Artery Dis200617637016374144
   PubMed Web of Science ®Google Scholar
• KhattabAABrodersenBSchuermann-KuchenbrandtDExtracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectorisInt J Cardiol2007121848517097167
   PubMed Web of Science ®Google Scholar
• LeschkeMSchoebelFCMecklenbeckWLong-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trialJ Am Coll Cardiol1996275755848606267
   PubMed Web of Science ®Google Scholar
• KimMCKiniASharmaSKRefractory angina pectoris: mechanism and therapeutic optionsJ Am Coll Cardiol200239692393411897431
   PubMed Web of Science ®Google Scholar
• The Framingham Heart Study site: http://www.framinghamheartstudy.org. Accessed Apr 2, 2010.
   Google Scholar
• KannelWBDawberTRKaganARevotskieNStokesJIIIFactors of risk in the development of coronary heart disease – six-year follow-up experience: The Framingham StudyAnn Intern Med196155335013751193
   PubMed Web of Science ®Google Scholar
• WilsonPWFD’AgostinoRLevyDBelangerASilbershatzHKannelWPrediction of coronary heart disease using risk factor categoriesCirculation199897183718479603539
   PubMed Web of Science ®Google Scholar
• WilsonPClustering of risk factors, obesity, and syndrome XNutr Clin Care19981Suppl4450
   Google Scholar
• BrotmanDWalkerELauerMSO’BrienRGIn search of fewer independent risk factorsArch Intern Med200516513814515668358
   PubMedGoogle Scholar
• MayoWThe aims and ideals of the American Medical Association. Address given at: the 66th Annual Meeting of the National Education Association; 1928 Jul 1–6; MinneapolisProc Natl Educ Assoc192866158163
   Google Scholar
• GonçalvesIStenströmKSkogGMattssonSNitulescuMNilssonJShort communication: dating Components of human atherosclerotic plaquesCirc Res20101061174117720167929
   PubMed Web of Science ®Google Scholar
• PasterkampGde KleijnDCold war battle against hot atherosclerotic plaquesCirc Res20101061017101820360263
   PubMed Web of Science ®Google Scholar
• BanksJMarmotMOldfieldZSmithJPDisease and disadvantage in the United States and in EnglandJAMA20062952037204516670412
   PubMed Web of Science ®Google Scholar
• StarfieldBHydeJGervasJHeathIThe concept of prevention: a good idea gone astrayJ Epidemiol Community Health20086258058318559439
   PubMed Web of Science ®Google Scholar
• KullerLHNutrition, lipids, and cardiovascular disease: clinical benefits without biochemical effects and biochemical effects without clinical benefitsCurr Cardiovasc Risk Reports20082914
   Google Scholar
• YusufSHawkenSOunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet200436493795215364185
   PubMed Web of Science ®Google Scholar
• HuGTuomilehtoJSilventoinenKSartiCMännistöSJousilahtiPBody mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific strokeArch Intern Med20071671420142717620537
   PubMed Web of Science ®Google Scholar
• MaruthurNMWangNYAppelLJLifestyle interventions reduce coronary heart disease risk: results from the PREMIER trialCirculation20091192026203119349322
   PubMed Web of Science ®Google Scholar
• RogerVLLifestyle and cardiovascular health: individual and societal choices [editorial]JAMA2009302443743919622826
   PubMed Web of Science ®Google Scholar
• DjousséLDriverJAGazianoJMRelation between modifiable lifestyle factors and lifetime risk of heart failureJAMA2009302439440019622818
   PubMed Web of Science ®Google Scholar
• FormanJPStampferMJCurhanGCDiet and lifestyle risk factors associated with incident hypertension in womenJAMA2009302440141119622819
   PubMed Web of Science ®Google Scholar
• FordESBergmannMMKrögerJSchienkiewitzAWeikertCBoeingHHealthy living is the best revenge: findings from the European prospective investigation into cancer and nutrition – potsdam studyArch Intern Med82009169151355136219667296
   PubMedGoogle Scholar
• KatzDLLife and death, knowledge and power: why knowing what matters is not what’s the matterArch Intern Med2009169151362136319667297
   PubMed Web of Science ®Google Scholar
• MozaffarianDKamineniACarnethonMDjousséLMukamalKJSiscovickDLifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health studyArch Intern Med200916979880719398692
   PubMed Web of Science ®Google Scholar
• ChiuveSEMcCulloughMLSacksFMRimmEBHealthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and anti-hypertensive medicationsCirculation200611416016716818808
   PubMed Web of Science ®Google Scholar
• ChowCKJollySRao-MelaciniPFoxKAAnandSSYusufSAssociation of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromesCirculation201012175075820124123
   PubMed Web of Science ®Google Scholar
• PatelNBBaladyGJThe rewards of good behaviorCirculation201012173373520124131
   PubMed Web of Science ®Google Scholar
• DanaeiGRimmEBOzaSKulkarniSCMurrayCEzzatiMThe promise of prevention: the effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United StatesPLoS Med201073e100024820351772
   PubMed Web of Science ®Google Scholar
• PhillipsLSTwomblyJGIt’s time to overcome clinical inertiaAnn Intern Med200814878378518490691
   PubMed Web of Science ®Google Scholar
• RoseGIncubation period of coronary heart diseaseInt J Epidemiol200534224224415764698
   PubMed Web of Science ®Google Scholar
• LabartheDRPreventing the risk to heart health, from womb to tombCVD Prevention19981259265
   Google Scholar
• SnydermanRDinanMAImproving health by taking it personalJAMA2010303436336420103762
   PubMed Web of Science ®Google Scholar
• KvaavikEBattyGDUrsinGHuxleyRGaleCRInfluence of individual and combined health behaviors on total and cause-specific mortality in men and women: the United Kingdom health and lifestyle surveyArch Intern Med2010170871171820421558
   PubMed Web of Science ®Google Scholar
• CarnethonMWhitselLPFranklinBAfor the American Heart Association Advocacy Coordinating Committee; Council on Epidemiology and Prevention; Council on the Kidney in Cardiovascular Disease; and Council on Nutrition, Physical Activity and MetabolismWorksite wellness programs for cardiovascular disease prevention: a policy statement from the American Heart AssociationCirculation20091201725174119794121
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDAdamsRJBrownTMfor American Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2010 update: a report from the American Heart AssociationCirculation2010121e46e21520019324
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDHongYLabartheDfor American Heart Association Strategic Planning Task Force and Statistics CommitteeDefining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyondCirculation201012158661320089546
   PubMed Web of Science ®Google Scholar
• StrasserTReflections on cardiovascular diseasesInterdisc Sci Rev19783225230
   Web of Science ®Google Scholar
• RoseGStrategy of prevention: lesions from cardiovascular diseaseBr Med J (Clin Res Ed)198128218471851
   PubMed Web of Science ®Google Scholar
• JohnsonRKAppelLJBrandsMfor the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism and the Council on Epidemiology and PreventionDietary sugars intake and cardiovascular health: a scientific statement from the American Heart AssociationCirculation20091201011102019704096
   PubMed Web of Science ®Google Scholar
• Bethesda, National Heart, Lung, and Blood InstituteMorbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood DiseasesNational Institutes of Health2009
   Google Scholar
• CapewellSFordESCroftJBCritchleyJAGreenlundKJLabartheDRCardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of AmericaBull World Health Organ20108812013020428369
   PubMed Web of Science ®Google Scholar
• Department of Health and Human ServicesHealthy People 2010: Understanding and Improving Health and Objectives for Improving HealthWashington, DCGovernment Printing Office2000 Available at: http://www.cdc.gov/nchs/healthy_people.htm. Accessed Apr 4, 2010.
   Google Scholar
• FrakerTDJrFihnSDfor 2002 Chronic Stable Angina Writing Committee2007chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable anginaJ Am Coll Cardiol2007502264227418061078
   PubMed Web of Science ®Google Scholar
• RedbergRFBenjaminEJBittnerVACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women’s Health ResearchCirculation200912012961336 andJ Am Coll Cardiol20095413641405
   PubMed Web of Science ®Google Scholar
• MoscaLBankaCLBenjaminEJEvidence-based guidelines for cardiovascular disease prevention in women: 2007 updateCirculation20071151481150117309915
   PubMed Web of Science ®Google Scholar
• SmithSCJrAllenJBlairSNAHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood InstituteJ Am Coll Cardiol2006472130213916697342
   PubMed Web of Science ®Google Scholar
• deBGAmbrosioniEBorch-JohnsenKEuropean guidelines on cardiovascular disease and prevention in clinical practiceAtherosclerosis200317114515514686332
   PubMed Web of Science ®Google Scholar
• JBS 2Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practiceHeart200591Suppl 5v1v5216365341
   PubMedGoogle Scholar
• GrahamIAtarDBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice: executive summaryEur Heart J2007282375241417726041
   PubMed Web of Science ®Google Scholar
• BassandJPHammCWArdissinoDfor The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of CardiologyGuidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromesEur Heart J2007281598166017569677
   PubMed Web of Science ®Google Scholar
• AndersonJLAdamsCDAntmanEMACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction)J Am Coll Cardiol200750e1e15717692738
   PubMed Web of Science ®Google Scholar
• CroweELovibondKGrayHfor Guideline Development GroupEarly management of unstable angina and non-ST elevation myocardial infarction: summary of NICE guidanceBMJ2010340c113420335335
   PubMedGoogle Scholar
• GibbonsRJBaladyGJBeasleyJWfor ACC/AHA Guidelines for Exercise TestingA report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing)J Am Coll Cardiol19973012603119207652
   PubMed Web of Science ®Google Scholar
• KingSBSmithSCJrHirshfeldJWJr2007 focused update of the 2005 guideline update for percutaneous coronary intervention American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing CommitteeJ Am Coll Cardiol20085117220918191745
   PubMed Web of Science ®Google Scholar
• CushmanWCEvansGWByingtonRPfor the ACCORD study groupEffects of intensive blood pressure control in type 2 diabetes mellitusNew Engl J Med2010362171575158520228401
   PubMed Web of Science ®Google Scholar
• NilssonPMACCORD and risk-factor control in type 2 diabetesNew Engl J Med2010362171628163020228405
   PubMed Web of Science ®Google Scholar
• CurrieCJPetersJPTynanASurvival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort studyLancet2010375971348148920110121
   PubMed Web of Science ®Google Scholar
• BalkauBSimonDSurvival in people with type 2 diabetes as a function of HbA1cLancet2010375971343844020110122
   PubMed Web of Science ®Google Scholar
• FeldmanDNGadeCLSlotwinerAJComparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry)Am J Cardiol2006981334133917134624
   PubMed Web of Science ®Google Scholar
• KirtaneAJCohenDJWhen is better not good enough? Insights from the COURAGE economic studyCirc Cardiovasc Qual Outcomes200814620031780
   PubMed Web of Science ®Google Scholar
• LinGADudleyRALucasFLMalenkaDJVittinghoffERedbergRFFrequency of stress testing to document ischemia prior to elective percutaneous coronary interventionJAMA20083001765177318854538
   PubMed Web of Science ®Google Scholar
• KatritsisDGIoannidisJPPercutaneous coronary intervention versus conservative therapy in non-acute coronary artery disease: a meta-analysisCirculation20051112906291215927966
   PubMed Web of Science ®Google Scholar
• BodenWEO’RourkeRATeoKKfor the COURAGE Trial Research GroupOptimal medical therapy with or without PCI for stable coronary diseaseN Engl J Med2007356151503151617387127
   PubMed Web of Science ®Google Scholar
• StoneGWMosesJWEllisSGSafety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsN Engl J Med2007356998100817296824
   PubMed Web of Science ®Google Scholar
• GargSSerruysPWDrug-eluting stents: a reappraisalHeart20109648949320350985
   PubMed Web of Science ®Google Scholar
• BhattDLControversies in non-ST-elevation acute coronary syndromes and percutaneous coronary interventionsCleve Clin J Med20107710110920124267
   PubMed Web of Science ®Google Scholar
• HilliardAAFromAMLennonRJPercutaneous revascularization for stable coronary artery disease: temporal trends and impact of drug-eluting stentsJ Am Coll Cardiol Intv20103172179
   Google Scholar
• CostaJRJrSousaAMoreiraACIncidence and predictors of very late (≥4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registryJ Am Coll Cardiol Intv201031218
   Google Scholar
• WindeckerSRaberLThe DESIRE-Late registry: what is left to be desiredJ Am Coll Cardiol Intv201031921
   Google Scholar
• NewbyLKPetersonEDDoes ranolazine have a place in the treatment of acute coronary syndromes?JAMA2007297161823182517456825
   PubMed Web of Science ®Google Scholar
• SerruysPWUngerFSousaJEComparison of coronary-artery bypass surgery and stenting for the treatment of multivessel diseaseN Eng J Med20013441511171124
   PubMed Web of Science ®Google Scholar
• SdringolaSLoghinCBoccalandroFGouldKLMechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-upJ Nucl Med200647596716391188
   PubMed Web of Science ®Google Scholar
• HochmanJSStegPGDoes preventive PCI workN Eng J Med200735615721574
   PubMed Web of Science ®Google Scholar
• PetersonEDDaiDDeLongERfor NCDR Registry ParticipantsContemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data RegistryJ Am Coll Cardiol2010551923193220430263
   PubMed Web of Science ®Google Scholar
• WeintraubWSBodenWEZhangZfor Department of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study CoordinatorsCost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patientsCirc Cardiovasc Qual Outcomes20081122020031783
   PubMed Web of Science ®Google Scholar
• WeintraubWSSpertusJAKolmPfor the COURAGE Trial Research GroupEffect of PCI on quality of life in patients with stable coronary diseaseN Engl J Med200835967768718703470
   PubMed Web of Science ®Google Scholar
• DavidsonMHClinical significance of statin pleiotropic effects: hypotheses versus evidenceCirculation20051112280228115883224
   PubMed Web of Science ®Google Scholar
• ShawLJBermanDSMaronDJOptimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudyCirculation20081171283129118268144
   PubMed Web of Science ®Google Scholar
• DiamondGAKaulSCOURAGE under fire. On the management of stable coronary diseaseJ Am Coll Cardiol2007501604160917936162
   PubMed Web of Science ®Google Scholar
• PetersonEDRumsfeldJSFinding the courage to reconsider medical therapy for stable anginaN Engl J Med200835975175318703479
   PubMed Web of Science ®Google Scholar
• KereiakesDJTeirsteinPSSarembockIJThe truth and consequences of the COURAGE trialJ Am Coll Cardiol2007501598160317936161
   PubMed Web of Science ®Google Scholar
• MaronDJBodenWEO’RourkeRAfor the COURAGE Trial Research GroupIntensive multifactorial intervention for stable coronary artery disease. Optimal medical therapy in the COURAGE trialJ Amer Col Cardiol2010551313481358
   PubMed Web of Science ®Google Scholar
• O’GaraPTThe COURAGE trial: can we deliver on its promise?J Am Coll Cardiol201055131359136120338497
   PubMed Web of Science ®Google Scholar
• CicconeMMAquilinoACorteseFFeasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo)Vasc Health Risk Manag2010629730520479952
   PubMedGoogle Scholar
• SchömigAMehilliJde WahaASeyfarthMPacheJKastratiAA meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery diseaseJ Am Coll Cardiol20085289490418772058
   PubMed Web of Science ®Google Scholar
• O’RourkeRAOptimal medical therapy is a proven option for chronic stable anginaJ Am Coll Cardiol20085290590718772059
   PubMed Web of Science ®Google Scholar
• MariePYDanchinNDurandJFLong-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclideangiographic dataJ Am Coll Cardiol1995268798867560612
   PubMed Web of Science ®Google Scholar
• JahnkeCNagelEGebkerRPrognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imagingCirculation20071151769177617353441
   PubMed Web of Science ®Google Scholar
• MinJKShawLJDevereuxRBPrognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortalityJ Am Coll Cardiol2007501161117017868808
   PubMed Web of Science ®Google Scholar
• DaviesRFGoldbergADFormanSAsymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularizationCirculation199795203720439133513
   PubMed Web of Science ®Google Scholar
• KatritsisDGMeierBPercutaneous coronary intervention for stable coronary artery diseaseJ Am Coll Cardiol20085288989318772057
   PubMed Web of Science ®Google Scholar
• CaliffRMArmstrongPWCarverJRTask Force 5. Stratification of patients into high-, medium-, and low-risk subgroups for purposes of risk factor managementJ Am Coll Cardiol19962796410478609362
   PubMed Web of Science ®Google Scholar
• BramlagePMesserCBitterlichNThe effect of optimal medical therapy on 1-year mortality after acute myocardial infarctionHeart20109660460920353936
   PubMed Web of Science ®Google Scholar
• CavenderMAAlexanderKPBroderickSLong-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery diseaseAm Heart J2009158693394019958859
   PubMed Web of Science ®Google Scholar
• HannanELRaczMJGoldJAdherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practiceCirculation200912126727520048207
   PubMed Web of Science ®Google Scholar
• PatelMRDehmerGJHirshfeldJWSmithPKSpertusJAACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association and the American Society of Nuclear Cardiology American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed TomographyJ Am Coll Cardiol20095353055319195618
   PubMed Web of Science ®Google Scholar
• Executive Summary. Comparative effectiveness of percutaneous coronary interventions and coronary artery bypass grafting for coronary artery disease. Agency for Healthcare Research and Quality Pub. No. 08-EHC002-1. 2007 Oct 15. Available at: www.effectivehealthcare.ahrq.gov/reports/final.cfm. Accessed May 1, 2010.
   Google Scholar
• KingSBIIIMarshallJJTummalaPERevascularization for coronary artery disease: stents versus bypass surgeryAnnu Rev Med20106119921319824825
   PubMed Web of Science ®Google Scholar